DOCSLIB.ORG

Pre-Stroke Warfarin Enhancement of Collateralization

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pre-Stroke Warfarin Enhancement of Collateralization Zhu et al. BMC Neurology (2018) 18:194 https://doi.org/10.1186/s12883-018-1200-7 RESEARCH ARTICLE Open Access Pre-stroke warfarin enhancement of collateralization in acute ischemic stroke: a retrospective study Jiaying Zhu1,2†, Mengmeng Ma1†, Yijia Guo1, Muke Zhou1, Jian Guo1 and Li He1* Abstract Background: Warfarin therapies not only are used to prevent stroke in patients with high risk of cardioembolism such as patients with atrial fibrillation (AF) and rheumatic heart disease (RHD), but also was associated with lower stroke severity and more favorable functional outcomes in patients with acute ischemic stroke due to middle cerebral artery occlusion. It was speculated that pre-stroke warfarin may promote collateralization and result in reduced stroke severity. This study aimed to investigate the association between pre-stroke warfarin use and leptomeningeal collaterals in patients with acute ischemic stroke due to occlusion of the middle cerebral artery. Methods: We enrolled consecutive acute ischemic stroke patients (occlusion of the middle cerebral artery within 24 h) with known history of AF and/or RHD at the neurology department of the West China Hospital from May 2011 to April 2017. Computed tomography angiography (CTA) before treatment was used to detect the thrombus. Regional leptomeningeal collateral (rLMC) score based on CTA images was used to assess collateral circulation. Prior use of warfarin was recorded. Univariate and multivariate analyses were performed to detect the association of prior warfarin use with the collateral circulation. Results: A total of 120 patients were included; 29 (24.2%) were taking warfarin before stroke. The international normalized ratio (INR) in patients with prior warfarin use was 1.53 ± 1.00, compared with 1.02 ± 0.09 in patients without prior warfarin use (P < 0.001). Prior oral warfarin therapy was inversely associated with poor rLMC (OR=0. 07, 95%CI 0.01–0.44, P = 0.005). There were no associations between prior warfarin use and initial stroke severity or functional outcomes at 3 months. Conclusion: Warfarin use seems improve collateralization in patients with acute stroke. However, clinical controlled studies should be used to verify this claim. Keywords: Warfarin, Acute ischemic stroke, Collateral circulation Background outcome in acute ischemic stroke [3–6]. Collateral blood Leptomeningeal collaterals are pre-existing anasto- vessels could be a therapeutic target in acute ischemic moses of distal regions of intracerebral small blood stroke [2]. However, preexisting collaterals depend on car- vessels [1, 2]. Collaterals provide the brain tissue with diac and pulmonary illnesses, metabolic syndrome, hyper- supplementary blood flow in the case of occlusion of uricemia, aging, and genetic factors [2, 4, 7, 8]. Although primary intracranial arteries to protect brain tissue there are no pharmacologic treatments proven to promote against irreversible damage [2]. Patients with good cerebral collateralization currently, some conventional leptomeningeal collaterals usually have lower severity stroke treatments may be available to enhance the collat- of stroke, better response to therapy, and better clinical eral circulation [6]. Statins, which have modest antithrom- botic pleiotropic effects, have been shown to be associated * Correspondence: [email protected] with the presence of better collaterals in patients with †Jia Ying Zhu and Mengmeng Ma contributed equally to this work. 1Department of Neurology, West China Hospital, Sichuan University, acute stroke [9]. Chengdu, China Full list of author information is available at the end of the article © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Zhu et al. BMC Neurology (2018) 18:194 Page 2 of 7 In addition, numerous studies have demonstrated that Maximum-intensity projection images (20 mm) were oral anticoagulants (such as warfarin) reduced the risk reconstructed in the axial, sagittal, and coronal planes. of ischemic stroke [10]. Warfarin was also associated with lower stroke severity and more favorable func- Leptomeningeal collateral flow assessment tional outcomes when stroke occurs [11–13]. Although We assessed the degree of leptomeningeal collateral flow the mechanism for pre-stroke warfarin lowering stroke using the regional leptomeningeal collateral (rLMC) score severity and improving functional outcomes was not (20 points) [3]. The rLMC score is based on scoring the very clear, two hypothesizes have been suggested. First, pial and lenticulostriate arteries in six MCA regions pre-stroke warfarin use may prevent thrombus forma- (M1-M6) and in the anterior cerebral artery region and tion and reduce the size of thrombi. Smaller thrombi the basal ganglia (0 = no; 1 = less; 2 = equal or more prom- cause distal infarctions and lower stroke severity and a inent compared with a matching region in the pial artery more favorable clinical outcome [14, 15]. Secondly, of the contralateral hemisphere). The arteries in the Syl- pre-stroke warfarin use may promote collateralization vian sulcus are given a higher score: 0 = not seen; 2 = less; since that the patients who used warfarin before stroke 4 = same or more prominent compared with the opposite had lower stroke severity comparing with not using Sylvian sulcus. An rLMC score of 0–10 was defined as warfarin even though the patients of two groups had poor collateral flow, 11–16 was defined as moderate col- the similar thrombi and arterial occlusion site [16, 17]. lateral flow, and 17–20 was defined as good collateral flow Then it was speculated that pre-stroke warfarin may [3]. The assessment was performed by four radiologists promote collateralization and result in reduced stroke with extensive experience in acute stroke imaging. The severity. However, whether the association exit between average score was used as the final score for the analyses. pre-stroke warfarin use and collaterals still needs to be clarified. In this study, we aimed to evaluate the associ- Data collection ation between pre-stroke warfarin use and collaterals in Clinical variables (age, gender, stroke risk factors, ad- acute ischemic stroke patients presenting with occlu- mission examinations, previous medications, thrombo- sion of the middle cerebral artery. lytic therapy, and hemorrhagic transformation) were collected for each patient from the stroke database. All Methods biochemical indexes were measured within 24 h of ad- Study population mission. The patient was considered to be using war- We performed a retrospective analysis of demographic, farin if they had been using it for at least 3 months clinical, and radiographic data in consecutive patients prior to stroke and were still using warfarin when at the Neurology Department of West China Hospital stroke occurred. Neurological severity was assessed by between May 2011 and April 2017. The inclusion cri- trained neurologists using the National Institutes of teria were: (1) ≥18 years of age; (2) history of AF and/or Health Stroke Scale (NIHSS, < 5 was defined as mild RHD; (3) available computed tomography angiography stroke, 5–14 as moderate stroke, and > 14 as severe (CTA) images within 24h of symptom onset; and (4) stroke) [11, 18]. Intracerebral hemorrhage (ICH) was CTA detection of acute infarction due to occlusion of diagnosed according to the European Cooperative the M1 or M2 middle cerebral artery (MCA), with or Acute Stroke Study (ECASS) criteria. All patients were without occlusion of the internal carotid artery (ICA). managed optimally according to the current guidelines, The exclusion criteria were: (1) pre-stroke modified physicians’ experience, and patients’ comorbidities. Rankin Scale (mRS) score > 2; (2) severe extracranial Follow-up mRS at 3-month after discharge was used to vascular stenosis detected by CTA; or (3) < 90 days of assess the functional outcome. All data collectors were follow-up. blind to the baseline collateral status. Admission CT Statistical analysis All patients underwent non-contrast computed tomog- Statistical analysis was performed using SPSS 22.0 for raphy (NCCT) and CTA. Imaging was conducted on a Windows (IBM, Armonk, NY, USA). The patients were 128-slice Siemens SOMATOM Definition Flash double grouped as warfarin users vs. non-warfarin users. The source CT scanner. NCCT helical scans were potential determinants of collaterals evaluated based performed form the skull base to the vertex using the on previous reports in the literature were age, blood following parameters: 70 kV, 150 mA, and 5-mm colli- pressure, total cholesterol (treated as continuous vari- mation. CTA was performed using: 42 ml of contrast at ables), high-density lipoprotein cholesterol (HDL-C), 6 ml/s, 3 to 5 s delay from injection to scanning, 70 kV, and low-density lipoprotein cholesterol (LDL-C), and 150 mA, 0.5 s/rotation, and 1.25-mm thick slice. The history of stroke, TIA, hypertension, diabetes, hyper- CTA scan covered the carotid bifurcation to the vertex. cholesterolemia, and pre-stroke statin
Load more

Recommended publications
  • Coronary Collaterals and Risk for Restenosis After Percutaneous Coronary Interventions
    Meier et al. BMC Medicine 2012, 10:62 http://www.biomedcentral.com/1741-7015/10/62 RESEARCH ARTICLE Open Access Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta- analysis Pascal Meier1*†, Andreas Indermuehle2†, Bertram Pitt3, Tobias Traupe4, Stefano F de Marchi5, Tom Crake1, Guido Knapp6, Alexandra J Lansky7 and Christian Seiler4 Abstract Background: The benefit of the coronary collateral circulation (natural bypass network) on survival is well established. However, data derived from smaller studies indicates that coronary collaterals may increase the risk for restenosis after percutaneous coronary interventions. The purpose of this systematic review and meta-analysis of observational studies was to explore the impact of the collateral circulation on the risk for restenosis. Methods: We searched the MEDLINE, EMBASE and ISI Web of Science databases (2001 to 15 July 2011). Random effects models were used to calculate summary risk ratios (RR) for restenosis. The primary endpoint was angiographic restenosis > 50%. Results: A total of 7 studies enrolling 1,425 subjects were integrated in this analysis. On average across studies, the presence of a good collateralization was predictive for restenosis (risk ratio (RR) 1.40 (95% CI 1.09 to 1.80); P = 0.009). This risk ratio was consistent in the subgroup analyses where collateralization was assessed with intracoronary pressure measurements (RR 1.37 (95% CI 1.03 to 1.83); P = 0.038) versus visual assessment (RR 1.41 (95% CI 1.00 to 1.99); P = 0.049). For the subgroup of patients with stable coronary artery disease (CAD), the RR for restenosis with ‘good collaterals’ was 1.64 (95% CI 1.14 to 2.35) compared to ‘poor collaterals’ (P = 0.008).
    [Show full text]
  • Clinical and Angiographic Features Associated with Coronary Collateralization in Stable Angina Patients with Chronic Total Occlusion
    Sun et al. / J Zhejiang Univ-Sci B (Biomed & Biotechnol) 2013 14(8):705-712 705 Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology) ISSN 1673-1581 (Print); ISSN 1862-1783 (Online) www.zju.edu.cn/jzus; www.springerlink.com E-mail: [email protected] Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion Zhen SUN§1, Ying SHEN§1, Lin LU1,2, Rui-yan ZHANG1, Li-jin PU1, Qi ZHANG1, Zheng-kun YANG1, Jian HU1, Qiu-jing CHEN2, Wei-feng SHEN†‡1,2 (1Department of Cardiology, Shanghai Ruijin Hospital, Shanghai 200025, China) (2Institute of Cardiovascular Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China) †E-mail: [email protected] Received June 18, 2013; Revision accepted June 28, 2013; Crosschecked June 18, 2013 Abstract: Objective: Coronary collateral circulation is an alternative source of blood supply to myocardium in the presence of advanced coronary artery disease. We sought to determine which clinical and angiographic variables are associated with collateral development in patients with stable angina and chronic total coronary occlusion. Methods: Demographic variables, biochemical measurements, and angiographic findings were collected from 478 patients with stable angina and chronic total coronary occlusion. The presence and extent of collaterals supplying the distal aspect of a total coronary occlusion from the contra-lateral vessel were graded from 0 to 3 according to the Rentrop scoring system. Results: Low (Rentrop score of 0 or 1) and high (Rentrop score of 2 or 3) coronary collateralizations were detected in 186 and 292 patients, respectively. Despite similar age, cigarette smoking, and medical treatment, patients with low collateralization were female in a higher proportion and less hypertensive, and had higher rates of type 2 diabetes and dyslipidemia than those with high collateralization (for all comparisons, P<0.05).
    [Show full text]
  • A New Risk Scoring Model for Prediction of Poor Coronary
    Cardiology Journal 2016, Vol. 23, No. 1, 107–113 DOI: 10.5603/CJ.a2015.0064 Copyright © 2016 Via Medica ORIGINAL ARTICLE ISSN 1897–5593 A new risk scoring model for prediction of poor coronary collateral circulation in acute non-ST-elevation myocardial infarction Mehmet İleri1, Ümit Güray1, Ertan Yetkin2, Havva Tuğba Gürsoy1, Pınar Türker Bayır1, Deniz Şahin1, Özgül Uçar Elalmış1, Yahya Büyükaşık3 1Department of Cardiology, Ankara Numune Education and Research Hospital, Ankara, Turkey 2Department of Cardiology, Ortadoğu Hospital, Mersin, Turkey 3Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey Abstract Background: We aimed to investigate the clinical features associated with development of coronary collateral circulation (CCC) in patients with acute non-ST-elevation myocardial infarction (NSTEMI) and to develop a scoring model for predicting poor collateralization at hospital admission. Methods: The study enrolled 224 consecutive patients with NSTEMI admitted to our coronary care unit. Patients were divided into poor (grade 0 and 1) and good (grade 2 and 3) CCC groups. Results: In logistic regression analysis, presence of diabetes mellitus, total white blood cell (WBC) and neutrophil counts and neutrophil to lymphocyte ratio (NLR) were found as inde- pendent positive predictors of poor CCC, whereas older age (≥ 70 years) emerged as a negative indicator. The final scoring model was based on 5 variables which were significant at p < 0.05 level following multivariate analysis. Presence of diabetes mellitus, and elevated total WBC (≥ 7.85 × 103/µL) and neutrophil counts (≥ 6.25 × 103/µL) were assigned with 2 points; high NLR (≥ 4.5) with 1 point and older age (≥ 70 years old) with –1 point.
    [Show full text]
  • A Review of Mechanisms on the Beneficial Effect of Exercise on Atherosclerosis
    Open Access Review Article DOI: 10.7759/cureus.11641 A Review of Mechanisms on the Beneficial Effect of Exercise on Atherosclerosis Daniel Chacon 1 , Brian Fiani 2 1. Medicine, Ross University School of Medicine, Bridgetown, BRB 2. Neurosurgery, Desert Regional Medical Center, Palm Springs, USA Corresponding author: Daniel Chacon, [email protected] Abstract Cardiovascular disease has affected a large percentage of the world, and as a result, we have had major advancements in pharmacological and procedural intervention of this disease. With the increased burden of rising healthcare costs, alternative treatment with exercise has shown to be much more cost effective and just as beneficial to patients compared to pharmacological and procedural treatment. We highlight some of the major mechanisms behind the beneficial effect of exercise on atherosclerosis and hope to encourage patients and providers to attempt to adopt this form of treatment that has not only shown to be beneficial to heart disease, but diseases such as diabetes and obesity as well. Categories: Cardiology, Family/General Practice, Preventive Medicine Keywords: atherosclerosis, cardiovascular disease, coronary artery disease, exercise Introduction And Background As the leading cause of mortality in the USA [1], cardiovascular disease has arguably become the standard to gauge an individual’s health. It is estimated that 610,000 people per year in the USA die of heart disease [2]. In the latest report by the American Heart Association, 365,914 Americans in 2017 died specifically due to coronary heart disease [3], otherwise known as atherosclerosis. Largely due to chronic inflammation in the coronary arteries, atherosclerosis results from the formation of an atheroma with the potential for luminal occlusion, resulting in decreased blood flow to the myocardium [4].
    [Show full text]
  • Interrogating the Functional Correlates of Collateralization in Patients with Intracranial Stenosis Using Multimodal Hemodynamic Imaging
    ORIGINAL RESEARCH FUNCTIONAL Interrogating the Functional Correlates of Collateralization in Patients with Intracranial Stenosis Using Multimodal Hemodynamic Imaging X B.A. Roach, X M.J. Donahue, X L.T. Davis, X C.C. Faraco, X D. Arteaga, X S.-C. Chen, X T.R. Ladner, X A.O. Scott, and X M.K. Strother ABSTRACT BACKGROUND AND PURPOSE: The importance of collateralization for maintaining adequate cerebral perfusion is increasingly recog- nized. However, measuring collateral flow noninvasively has proved elusive. The aim of this study was to assess correlations among baseline perfusion and arterial transit time artifacts, cerebrovascular reactivity, and the presence of collateral vessels on digital subtraction angiography. MATERIALS AND METHODS: The relationship between the presence of collateral vessels on arterial spin-labeling MR imaging and DSA was compared with blood oxygen level–dependent MR imaging measures of hypercapnic cerebrovascular reactivity in patients with symptomatic intracranial stenosis (n ϭ 18). DSA maps were reviewed by a neuroradiologist and assigned the following scores: 1, collaterals to the periphery of the ischemic site; 2, complete irrigation of the ischemic bed via collateral flow; and 3, normal antegrade flow. Arterial spin-labeling maps were scored according to the following: 0, low signal; 1, moderate signal with arterial transit artifacts; 2, high signal with arterial transit artifacts; and 3, normal signal. RESULTS: In regions with normal-to-high signal on arterial spin-labeling, collateral vessel presence on DSA strongly correlated with declines in cerebrovascular reactivity (as measured on blood oxygen level–dependent MR imaging, P Ͻ .001), most notably in patients with nonatherosclerotic disease.
    [Show full text]
  • Validation and Simplification of a Scoring Model Derived For
    İleri et al. Int J Clin Cardiol 2016, 3:087 Volume 3 | Issue 2 International Journal of ISSN: 2378-2951 Clinical Cardiology Research Article: Open Access Validation and Simplification of a Scoring Model Derived for Prediction of Poor Coronary Collateral Circulation in Acute Non-St Elevation Myocardial Infarction Mehmet İleri1*, Koray Gürsel1, Funda Başyiğit1, Pınar Türker Bayır1, Deniz Şahin1, Ümit Güray1, Özgül Uçar1, Burak Acer2 and Yahya Büyükaşık3 1Department of Cardiology, Ankara Numune Education and Research Hospital, Ankara, Turkey 2Department of Cardiology, Türkiye Yüksek İhtisas Education and Research Hospital, Ankara, Turkey 3Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey *Corresponding author: Mehmet İleri, Department of Cardiology, Ankara Numune Education and Research Hospital, Ankara, Turkey, Tel: +90 505 485 9803, E-mail: [email protected] myocardial infarction (NSTEMI), abrupt vessel occlusion results in Abstract myocardial necrosis in the jeopardized area. Angiographic collaterals Introduction and objective: The aim of this study was to provide to myocardial tissue distal to an acutely occluded coronary vessel validation and simplification of the scoring model derived for can reduce infarct size and risk for post-infarct complications as prediction of poor coronary collateral circulation (CCC) in acute well as infarct related mortality. These prognostic implications of non-ST elevation myocardial infarction (NSTEMI) in a population- collateral function, makes it necessary to have a better understanding based prospective cohort. of the factors promoting collateral development in acute setting of Patient and methods: The validation cohort consisted of 136 myocardial infarction. We recently developed a risk scoring model for consecutive patients with NSTEMI admitted to coronary care predicting poor collateralization in patients with NSTEMI at hospital units of three referral hospitals within 24 hours of symptom onset admission [1].
    [Show full text]
  • P27kip1 Knockout Enhances Collateralization in Response to Hindlimb Ischemia
    From the Western Vascular Society p27kip1 Knockout enhances collateralization in response to hindlimb ischemia Galit Ankri-Eliahoo, PhD,a Kevin Weitz, BS,a Timothy C. Cox, PhD,b and Gale L. Tang, MD,a,c Seattle, Wash Objective: The natural response to arterial occlusive disease is enlargement of collaterals; however, the molecular factors that control collateralization are not well understood. The gene p27Kip1 (p27) affects human response to arterial injury. Previous studies have shown that overexpression of p27 inhibits vascular endothelial and vascular smooth muscle cell (VSMC) proliferation and angiogenesis. To test the hypothesis that knockout of p27 would improve collateralization in reaction to L L ischemia, we performed in vivo and in vitro experiments using p27 knockout (p27 / ) and wild-type (wt) mice. L L Methods: Hindlimb ischemia was induced by left femoral artery ligation in p27 / and wt (C57BL/6) female mice. The mice underwent weekly laser Doppler perfusion imaging of the footpads until sacrifice on postoperative day 28 followed L L by microcomputed tomography scanning of both hindlimbs. VSMCs were isolated from p27 / and wt mice and used in migration and gel contraction assays in the absence and presence of the nonspecific matrix metalloproteinase (MMP) inhibitor BB94. MMP-2 and MMP-9 messenger RNA (mRNA) expression was measured by quantitative reverse L L transcription-polymerase chain reaction in p27 / and wt VSMCs. L L Results: p27 / mice reperfused more effectively than wt mice by laser Doppler starting from day 7 (ischemic/nonischemic ratio, 0.33 6 0.02 vs 0.25 6 0.02; P < .05) and continuing through day 28 (0.45 6 0.04 vs 0.31 6 0.04; P < .05).
    [Show full text]
  • Regulates Postnatal Ischemic and VEGF-Induced Angiogenesis Through the Protein Kinase A–Endothelial NOS Pathway
    Grb-2–associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A–endothelial NOS pathway Yao Lua,1, Yan Xionga,1, Yingqing Huoa, Jingyan Hanb, Xiao Yangc, Rongli Zhangd, De-Sheng Zhue, Stefan Klein-Heßlingf, Jun Lie, Xiaoyu Zhanga, Xiaofan Hana, Yanli Lia, Bin Sheng, Yulong Heg, Masabumi Shibuyah, Gen-Sheng Fengi, and Jincai Luoa,2 aLaboratory of Vascular Biology, Institute of Molecular Medicine; and bDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Tasly Microcirculation Research Center, Peking University, Beijing 100871, China; cGenetic Laboratory of Development and Disease, Institute of Biotechnology, Beijing 100071, China; dNon-Human Primate Center, Institute of Molecular Medicine; and eAnimal Center, Peking University, Beijing 100871, China; fDepartment of Molecular Pathology, Institute of Pathology, University of Würzburg, D-97080 Würzburg, Germany; gLaboratory of Vascular and Cancer Biology, Model Animal Research Institute, Nanjing University, Nanjing 210061, China; hDepartment of Molecular Oncology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan; and iDepartment of Pathology, School of Medicine, University of California at San Diego, La Jolla, CA 92093 Edited* by Napoleone Ferrara, Genentech, South San Francisco, CA, and approved January 5, 2011 (received for review June 30, 2010) The intracellular signaling mechanisms underlying postnatal an- phosphorylation and association with PI3K and the tyrosine phos- giogenesis are incompletely understood. Herein we show that phatase Shp2 (12). Recent in vitro studies showed that Gab1 is es- Grb-2–associated binder 1 (Gab1) plays a critical role in ischemic sential for VEGF signaling in promoting cell migration, survival, and VEGF-induced angiogenesis.
    [Show full text]
  • Noninvasive Assessment of Coronary Collaterals in Man by PET Perfusion Imaging
    Noninvasive Assessment of Coronary Collaterals in Man by PET Perfusion Imaging Linda L. Demer, K. Lance Gould, Richard A. Goldstein, and Richard L. Kirkeeide Division ofCardiology, Positron Diagnostic and Research Center, The University of Texas Medical School, Houston, Texas, and Division ofCardiology, University ofCalzfornia, Los Angeles, School ofMedicine, Los Angeles, California inadequate. Radioactive isotope techniques have now At present,coronarycollateralizationcannotbe identified made it possible to assess myocardial perfusion nonin or assessednoninvasivelyin patients.In animalstudies, vasively. coronarycollateralsare associatedwith coronarysteal, This study was undertaken to assess the effect of definedas a regionalfall in perfusionduringcoronary dipyridamole-induced coronary arteriolar vasodilation artenolar vasodilation. To determine the effect of coronary on perfusion of collateralized myocardium assessed by artenolar vasodilation on collateral bed perfusion in man, positron emission tomography (PET) in patients with myocardialperfusionimagingwas performedbefore and well-developed coronary collaterals compared to those afterpharmacologiccoronaryvasodilationinpatientswith with comparable coronary disease without collaterals. coronaryarterydisease(CAD).Regionalmyocardialactiv ity of @Rbor 13Nammonia was measured by positron emissiontomography(PET) at rest and with intravenous METHODS dipyndamole/handgnpstressin 28 patientswith angio One hundred and eleven patients underwent rest-stress PET graphiccollateralsand in 25 controlpatientswith
    [Show full text]
  • Contradictory Effect of Coronary Collateral Circulation on Regional Myocardial Perfusion That Assessed by Quantitative Myocardial Perfusion Scintigraphy
    Original Article Cardiol Res. 2021;12(3):193-200 Contradictory Effect of Coronary Collateral Circulation on Regional Myocardial Perfusion That Assessed by Quantitative Myocardial Perfusion Scintigraphy Semra Ozdemira, c , Ahmet Barutcub , Ercan Aksitb , Ali Duygub , Fulya Koc Ozturka Abstract Keywords: Coronary collateral circulation; Myocardial perfusion scintigraphy; Gated; Phase analysis; Myocardial function Background: Previous studies showed conflicting results about the contribution of coronary collateral circulation (CCC) to myocardial perfusion and function. The aim of this study was to investigate these contradictory problems by gated myocardial perfusion scintigraphy Introduction (gated MPS) for the first time. Methods: The current cohort was retrospectively selected among pa- Coronary collateral circulation (CCC) is a natural anastomosis tients who underwent gated MPS and coronary angiography within 2 develops as a consequence of severe stenosis or total coronary months. Two different groups including 96 patients were assessed by occlusion in normal coronary circulation [1-3]. The presence gated MPS to detect the understanding of the miscellaneous effect of of different degrees of collateral circulation in patients with CCC on myocardial perfusion. Group 1 consisted of those who had similar levels of coronary artery disease suggests that this im- collateral arteries that were not-well-developed (Rentrop grade 0 - 1) portant phenomenon is developed by complex mechanisms [4, (n = 58), while group 2 consisted of those who had collateral arteries 5]. Evaluation and grading of CCC depend mainly on invasive that were well-developed (Rentrop grade 2 - 3) (n = 38). procedures such as coronary angiography [6-8]. It is gener- ally thought that the presence of CCC will protect myocardial Results: There was no statistically significant difference between perfusion and thus prevent ischemia and infarction.
    [Show full text]
  • Angiogenesis and Portal-Systemic Collaterals in Portal Hypertension
    Angiogenesis and portal-systemic collaterals in portal hypertension. , 2016; 15 (3): 303-313 303 CONCISE REVIEW May-June, Vol. 15 No. 3, 2016: 303-313 The Official Journal of the Mexican Association of Hepatology, the Latin-American Association for Study of the Liver and the Canadian Association for the Study of the Liver Angiogenesis and portal-systemic collaterals in portal hypertension Juan Cristóbal Gana,* Carolina A. Serrano,* Simon C. Ling** *Department of Pediatric Gastroenterology & Nutrition, Division of Pediatrics, Escuela de Medicina, Pontificia Universidad Católica de Chile. Chile. **Division of Gastroenterology, Hepatology & Nutrition, Department of Paediatrics, University of Toronto, and The Hospital for Sick Children, Toronto, Canada. ABSTRACT In patients with advanced liver disease with portal hypertension, portal-systemic collaterals contribute to circulatory disturbance, gas- trointestinal hemorrhage, hepatic encephalopathy, ascites, hepatopulmonary syndrome and portopulmonary hypertension. Angiogen- esis has a pivotal role in the formation of portal-systemic shunts. Recent research has defined many of the mediators and mechanisms involved in this angiogenic process, linking the central roles of hepatic stellate cells and endothelial cells. Studies of an- imal models have demonstrated the potential therapeutic impact of drugs to inhibit angiogenesis in cirrhosis. For example, inhibition of VEGF reduces portal pressure, hyperdynamic splanchnic circulation, portosystemic collateralization and liver fibrosis. An im- proved understanding of the role of other angiogenic factors provides hope for a novel targeted therapy for portal hypertension with a tolerable adverse effect profile. Key words. Angiogenesis. Portal hypertension. VEGF. Systemic collaterals. INTRODUCTION Prevention and improved management of portal hyper- tension and its complications are therefore important Portal hypertension and the formation of portal-sys- goals.
    [Show full text]
  • Therapeutic Sirna Targeting Endothelial KDR Decreases
    www.nature.com/scientificreports OPEN Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in Received: 26 July 2017 Accepted: 13 October 2017 portal hypertension Published: xx xx xxxx Javier Gallego1,2, Ester Garcia-Pras1,2, Marc Mejias1,2, Nuria Pell1,2, Ute Schaeper3 & Mercedes Fernandez1,2 Development of portosystemic collateral vessels and gastroesophageal varices is responsible for the most serious clinical consequences of portal hypertension, but efective clinical therapies are limited. Here we developed and investigated the therapeutic potential of an innovative liposomally- formulated short-interfering RNA (siRNA) technology based on clinical stage components, capable to attenuate production of the endothelial kinase insert domain receptor (KDR), which controls portosystemic collateralization and contributes to disease progression and aggravation. These siRNAs were frst validated in vitro, and then, their therapeutic potential on portosystemic collateralization and pathological angiogenesis was tested in vivo in mouse models of portal hypertension (portal vein-ligation). siRNAKDR-lipoplexes efciently transported siRNAKDR to vascular endothelial cells in mesenteric microvenules and portal vein of portal hypertensive mice, where collaterogenesis and angiogenesis take place. This systemic treatment signifcantly downregulated pathological KDR overexpression, without causing complete KDR knockout, preserving homeostatic baseline KDR levels and thus limiting adverse efects. siRNAKDR-lipoplex-induced
    [Show full text]